ATDC promotes the growth and invasion of hepatocellular carcinoma cells by modulating GSK-3 β/Wnt/β-catenin signaling.

This article is protected by copyright. All rights reserved.
PMID: 31168819 [PubMed - as supplied by publisher]

Source: Clinical and Experimental Pharmacology and Physiology - June 5, 2019 Category: Drugs & Pharmacology Authors: Li W, Xue H, Li Y, Li P, Ma F, Liu M, Kong S Tags: Clin Exp Pharmacol Physiol Source Type: research